Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
11/06/1997 | WO1997041233A1 Antiviral ricin-like proteins |
11/06/1997 | WO1997041232A1 Antagonists of interleukin-15 |
11/06/1997 | WO1997041231A1 Processed polypeptides with il-16 activity, process for preparing the same and their use |
11/06/1997 | WO1997041230A2 Cc-type chemokines |
11/06/1997 | WO1997041229A1 Antibodies against interferon alpha/beta receptor |
11/06/1997 | WO1997041226A2 Polynucleotides encoding the transcriptional repressor gcf2 of the epidermal growth factor receptor |
11/06/1997 | WO1997041225A2 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr] |
11/06/1997 | WO1997041223A1 Molecular clone of cgrp receptor component protein and uses thereof |
11/06/1997 | WO1997041222A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS |
11/06/1997 | WO1997041221A1 Metastasis-associated antigen and antibodies thereto |
11/06/1997 | WO1997041220A1 Von willebrand factor peptide derivatives and use therof as coagulant |
11/06/1997 | WO1997041206A2 Von willebrand factor multimerase |
11/06/1997 | WO1997041156A1 Novel compounds |
11/06/1997 | WO1997041155A2 Compositions and methods for isolating lung surfactant hydrophobic proteins sp-b and sp-c |
11/06/1997 | WO1997041154A1 Eosinophil eotaxin receptor |
11/06/1997 | WO1997041151A2 Choline binding proteins for anti-pneumococcal vaccines |
11/06/1997 | WO1997041150A2 Gene therapy for mitochondrial dna deffects using peptide nucleic acids |
11/06/1997 | WO1997041149A1 Peptide compositions which induce immune tolerance and methods of use |
11/06/1997 | WO1997041148A1 Specific immunophilin ligands as antiasthmatics and immunosuppressants |
11/06/1997 | WO1997041147A1 Novel compounds |
11/06/1997 | WO1997041146A1 Novel compounds |
11/06/1997 | WO1997041143A1 Novel synaptogyrin homolog |
11/06/1997 | WO1997041141A1 Methods and compounds for curing diseases caused by mutations |
11/06/1997 | WO1997041136A1 Suppressor mutations for common p53 cancer mutations |
11/06/1997 | WO1997041135A1 Novel compounds |
11/06/1997 | WO1997041115A1 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES |
11/06/1997 | WO1997040864A1 Method for making autologous fibrin sealant |
11/06/1997 | WO1997040861A1 Biological material free of viral and molecular pathogens and a process for the production thereof |
11/06/1997 | WO1997040857A1 Drug delivery using terminal complement components |
11/06/1997 | WO1997040855A1 Mammalian regulator of nonsense-mediated rna decay |
11/06/1997 | WO1997040854A2 Polypeptide conjugates for transporting substances across cell membranes |
11/06/1997 | WO1997040853A1 Pharmacologic, therapeutic and diagnostic regulation of fgf-1 export |
11/06/1997 | WO1997040852A1 Improving binding affinity of antigenic peptides for mhc molecules |
11/06/1997 | WO1997040851A1 Novel compounds |
11/06/1997 | WO1997040850A1 Erythropoietin solution preparation |
11/06/1997 | WO1997040849A1 Method for treating or preventing ischemia-reperfusion injury |
11/06/1997 | WO1997040848A1 Use of prolactin as a tgf-beta antagonist |
11/06/1997 | WO1997040847A1 Therapeutic and drug screening methods for the treatment and prevention of neuronal disease |
11/06/1997 | WO1997040846A1 COMBINED USE OF GnRH AGONIST AND ANTAGONIST |
11/06/1997 | WO1997040840A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent |
11/06/1997 | WO1997040832A1 Use of dipeptidyl peptidase iv effectors for lowering the blood glucose level in mammals |
11/06/1997 | WO1997040819A1 Methods of dry powder inhalation |
11/06/1997 | WO1997040811A1 Storage stable dentifrice composition containing casein glycomacropeptide |
11/06/1997 | WO1997040809A2 METHOD OF ENHANCING EFFECT OF NEUROTROPHIN WITH ANALOGUES OF p75NTR367-379 |
11/06/1997 | WO1997035969A3 Peptide ligands of the urokinase receptor |
11/06/1997 | WO1997033608A3 Antagonism of endothelin actions |
11/06/1997 | WO1997032598A3 Vaccines |
11/06/1997 | WO1997027284A3 Human rad50 and septin-2 genes and methods of use |
11/06/1997 | DE19617203A1 Recombinant interleukin 16 |
11/06/1997 | DE19617202A1 Recombinant interleukin 16 |
11/06/1997 | CA2253433A1 Mammalian regulator of nonsense-mediated rna decay |
11/06/1997 | CA2253313A1 Method for treating or preventing ischemia-reperfusion injury |
11/06/1997 | CA2253300A1 Biological material free of viral and molecular pathogens and a process for the production thereof |
11/06/1997 | CA2253259A1 Processed polypeptides with il-16 activity, process for preparing the same and their use |
11/06/1997 | CA2253252A1 Choline binding proteins for anti-pneumococcal vaccines |
11/06/1997 | CA2253233A1 Process for producing maturation bone morphogenetic protein |
11/06/1997 | CA2252862A1 P1, p4-dithio-p2,p3-monochloromethylene 5', 5'''-diadenosine p1, p4-tetraphosphate as antithrombotic agent |
11/06/1997 | CA2252850A1 Eosinophil eotaxin receptor |
11/06/1997 | CA2252814A1 Methods of dry powder inhalation |
11/06/1997 | CA2252762A1 Methods and compounds for curing diseases caused by mutations |
11/06/1997 | CA2252706A1 Polypeptide conjugates for transporting substances across cell membranes |
11/06/1997 | CA2252557A1 Antagonists of interleukin-15 |
11/06/1997 | CA2252469A1 Method of enhancing effect of neurotrophin with analogues of p75ntr367-379 |
11/06/1997 | CA2252468A1 Peptide compositions which induce immune tolerance and methods of use |
11/06/1997 | CA2252432A1 Mammalian mixed lymphocyte receptors, chemokine receptors [mmlr-ccr] |
11/06/1997 | CA2251813A1 5,6,7,8-tetrahydropyrido¬2,3-d|pyrimidines |
11/06/1997 | CA2232682A1 Use of prolactin as a tgf-beta antagonist |
11/06/1997 | CA2230866A1 Human p2x4 receptor splice-variants |
11/05/1997 | EP0805206A2 Human cartilage glycoprotein |
11/05/1997 | EP0805204A2 Epididymis-specific receptor protein and its use |
11/05/1997 | EP0805203A1 The use of a substance which prevents HGS/SF from binding with Met |
11/05/1997 | EP0805162A1 Peptide determinant associated with immunity |
11/05/1997 | EP0805149A1 Novel 2,3-diketopiperazine derivative or salt thereof |
11/05/1997 | EP0804933A2 Storage-stable fibrinogen preparations |
11/05/1997 | EP0804931A2 Peritoneal dialysis solutions and their use to minimize injury to mesothelial cells |
11/05/1997 | EP0804930A1 Novel remedy for respiratory-tract viral disease |
11/05/1997 | EP0804883A2 Animal feed |
11/05/1997 | EP0804728A1 Assay, receptor proteins and ligands |
11/05/1997 | EP0804617A1 Bcl-x/bcl-2 associated cell death regulator |
11/05/1997 | EP0804613A1 Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins |
11/05/1997 | EP0804609A1 NOVEL p53 RESPONSE GENES |
11/05/1997 | EP0804605A2 Liposome-mediated transfection of central nervous system cells |
11/05/1997 | EP0804602A1 Hsv viral vector |
11/05/1997 | EP0804601A1 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle |
11/05/1997 | EP0804598A1 Recombinant rna viral vector and method of preparing the same |
11/05/1997 | EP0804596A1 FUSION PROTEINS WITH CYTOTOXIC ACTIVITY AGAINST CELLS OVEREXPRESSING erbB3 AND/OR erbB4 |
11/05/1997 | EP0804595A1 Synthetic proteins as implantables |
11/05/1997 | EP0804593A1 Recombinant hk2 polypeptide |
11/05/1997 | EP0804591A1 Serum paraoxonase |
11/05/1997 | EP0804585A1 Capl-specific oligonucleotides and methods of inhibiting metastatic cancer |
11/05/1997 | EP0804584A1 New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents |
11/05/1997 | EP0804581A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production |
11/05/1997 | EP0804580A1 Calcium binding recombinant antibody against protein c |
11/05/1997 | EP0804578A1 Il-2r-associated polypeptide and dna molecules coding therefor |
11/05/1997 | EP0804577A2 cDNA ENCODING A BMP TYPE II RECEPTOR |
11/05/1997 | EP0804576A1 A novel haemopoietin receptor |
11/05/1997 | EP0804574A1 Human kappa opioid receptor, nucleic acids and uses thereof |
11/05/1997 | EP0804572A1 Protein tyrosine kinase agonist antibodies |
11/05/1997 | EP0804568A2 Multimeric forms of members of the steroid/thyroid superfamily of receptors with the ultraspiracle receptor |
11/05/1997 | EP0804567A1 Method for the ex vivo treatment of tumour cells from patients with cml |